期刊文献+

色胺酮抗恶性肿瘤分子机制研究进展 被引量:1

Research progress on the molecular mechanism of tryptanthrin against malignant tumors
下载PDF
导出
摘要 恶性肿瘤为全球主要公共卫生问题之一,手术切除、放射治疗、化学治疗等传统治疗方法虽然能取得较好的治疗效果,但不良反应较大,急需开发新型的治疗药物和技术以改善临床治疗现状。色胺酮为一种吲哚类衍生物,属于吲哚喹唑啉类生物碱,具有抗炎、抗菌、抗病毒等药理作用,在医疗领域有良好的开发和应用前景。目前研究发现,色胺酮在抗肿瘤方面的药物活性较为显著,能作用于乳腺癌、胶质瘤、白血病、皮肤癌等多种恶性肿瘤,显著提高恶性肿瘤的治疗效果。本文就近年来色胺酮治疗恶性肿瘤的分子机制相关研究进行综述,旨在为色胺酮应用于恶性肿瘤的临床治疗提供参考。 Malignant tumor is one of the major global public health problems.Although surgical resection,radiotherapy,chemotherapy and other traditional methods can achieve good therapeutic effect,but the adverse reactions are relatively large.It is urgent to develop new therapeutic drugs and technologies to improve the status of the clinical treatment.Tryptanthrin is an indole derivative,it belongs to indole quinazoline alkaloids.Tryptanthrin has many pharmacological effects such as anti-inflammatory,antibacterial and antiviral,and it has good development and application prospects in the medical field.At present,the researches have found that the anti-tumor drug activity of tryptanthrin is more significant,which can act on breast cancer,glioma,leukemia,skin cancer and other malignant tumors,and significantly improve the treatment effect for malignant tumors.This article reviews the related studies on the molecular mechanisms of tryptanthrin in treating malignant tumors,in order to provide the reference for the application of tryptanthrin in the clinical treatment of malignant tumors.
作者 周涵 魏静 李媛 谢敏 屈梦扬 方艳 ZHOU Han;WEI Jing;LI Yuan;XIE Min;QU Mengyang;FANG Yan(Department of Pathology,School of Basic Medicine,Shaanxi University of Chinese Medicine,Xi′an 712046,Shaanxi Province,China)
出处 《新乡医学院学报》 CAS 2022年第8期791-795,共5页 Journal of Xinxiang Medical University
基金 国家自然科学基金资助项目(编号:82003806) 国家级大学生创新训练项目(编号:S202010716029)。
关键词 色胺酮 恶性肿瘤 分子机制 tryptanthrin malignant tumor molecular mechanism
  • 相关文献

参考文献8

二级参考文献60

  • 1魏璇,张一兵,杜雪,马雪梅,杜秀英.P16蛋白在宫颈上皮内病变及宫颈癌中的表达及意义[J].实用癌症杂志,2014,29(3):276-277. 被引量:8
  • 2阮金兰,邹建华,蔡亚玲.大青叶化学成分研究[J].中国中药杂志,2005,30(19):1525-1526. 被引量:14
  • 3王翠玲,刘建利,沈小莉.天然产物色胺酮及其衍生物合成的研究进展[J].化学通报,2007,70(2):89-95. 被引量:5
  • 4曾嵘.c-myc的基因调节作用[J].国外医学(遗传学分册),1997,20(2):64-66. 被引量:12
  • 5王振义.白血病的诱导凋亡疗法.中国医学论坛报,2003,29(1):72-75.
  • 6Schindler F, Zahner H. Metabolic products of microorganisms. 91. Tryptanthrin, a tryptophan derived antibiotic from Candida lipolytica[J] .Arch Mikrobiol,1971,79(3) :187-203.
  • 7Danz H, Baumann D, Hamburger M. Quantitative determination of the dual COX-2/5-LOX inhibitor tryptanthrin in Isatis tinctoria by ESI-LC -MS [ J ]. Planta Med,2002,68 ( 2 ) : 152-7.
  • 8Honda G, Tabata M. Isolation of antifungal principle tryptanthrin from Strobilanthes cusia O. Kuntze [ J ]. Planta Medica, 1979,36 : 85-6.
  • 9Honda G ,Tosirisuk V ,Tabata M. Isolation of an antidermatophytic, tryptanthrin, from indigo plants, Polygonum tinctorium and lsatis tinctoria[ J ]. Planta Medica, 1980,38( 3 ) :275-6.
  • 10Mohn T, Potterat O, Hamburger M. Quantification of active principles and pigments in leaf extracts of lsatis tinctoria by HPLC/ UV/MS[ J]. Planta Med,2007,73(2 ) : 151-6.

共引文献40

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部